Dual targeting approach improves immunotherapy response in glioblastoma
Researchers from Â鶹ӳ» MD Anderson Cancer Center have found that simultaneously blocking two key ¡°don¡¯t eat me signals¡± found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy in models of glioblastoma (GBM), highlighting a promising strategy.
The study, published in Nature Communications, was co-led by Wen Jiang, M.D., Ph.D., associate professor of Radiation Oncology, and Betty...
Low testosterone levels may be associated with increased risk of prostate cancer progression during surveillance
Study found men with low?testosterone?levels?were?associated with a?60%?higher likelihood that prostate cancer...